Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,930,768
+$19,425,883 QoQ
Shares Held
421,444
+415.7% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#83
of 739 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $730,930,536 across 167 Biotechnology names. EXEL ranks #5 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,930,768 | 421,444 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,504,885 | 81,718 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,224,347 | 27,934 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,509,473 | 36,549 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $14,976,797 | 339,764 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $68,668,947 | 1,859,939 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $72,475,085 | 2,176,429 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $52,671,259 | 2,029,721 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $10,287,956 | 457,853 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $28,915,337 | 1,218,514 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $42,514,526 | 1,772,177 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $42,778,978 | 1,957,848 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,270,886 | 171,161 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $474,399 | 24,441 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $2,511,687 | 156,589 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,119,653 | 135,182 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,402,164 | 67,347 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $610,412 | 26,926 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $596,512 | 32,632 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $838,031 | 39,642 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $328,178 | 18,012 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,818,780 | 124,780 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $15,250,671 | 759,874 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $17,271,944 | 706,419 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $17,657,717 | 743,796 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $12,690,106 | 736,940 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||